|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 498/22 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 1557421 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04005541.0 |
| Date of filing the European patent application | 2004-03-09 | |
| (97) | Date of publication of the European application | 2005-07-27 |
| (45) | Date of publication and mention of the grant of the patent | 2007-05-09 |
| (46) | Date of publication of the claims translation | 2007-09-25 |
| (30) | Number | Date | Country code |
| MI20032144 | 2003-11-07 | IT |
| (72) |
Viscomi, Giuseppe C., IT
Campana, Manuela, IT
Braga, Dario, IT
Confortini, Donatella, IT
Cannata, Vincenzo, IT
Severini, Denis, IT
Righi, Paolo, IT
Rosini, Goffredo, IT
|
| (73) |
Alfasigma S.p.A.,
Viale Sarca n. 223, Milano (MI),
IT
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Rifaksimino kaip antibiotiko polimorfinės formos |
| Polymorphous form of rifaximin as antibiotic |
| Payment date | Validity (years) | Amount | |
| 2023-03-01 | 347.00 EUR |